DalsnaFinance › IPOs › FibroBiologics › IPO

FibroBiologics, Inc. IPO

Completed

FibroBiologics, Inc. completed its initial public offering on NASDAQ on January 31, 2024, pricing at $30.00 a share.

Ticker	FBLG
Exchange	NASDAQ
Status	Completed
Listing date	January 31, 2024
Offering price	$30.00
Shares offered	4,806,226
Total raised	$144M

The offering

FibroBiologics, Inc. sold 4,806,226 shares at $30.00 each on NASDAQ. Multiplied out, that is $144.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $144 million total recorded for the deal.

Company coverage

FibroBiologics, Inc. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for FibroBiologics, Inc.. This page is general information, not investment advice.